Patent intelligence · US
US 8071545
Therapies and compositions for controlling the stress mechanism and for stabilizing hemostasis in an organism
Therapies and compositions for controlling the stress mechanism and for stabilizing hemostasis in an organism
Patent details — US 8071545
- Jurisdiction
- US
- Status
- granted
- Grant date
- Dec 6, 2011
- Expiration
- Dec 1, 2031
- Applicant
- Lewis S. Coleman, MD, Inc.
- Claims
- 22
- CPC classes
- A61K, A61K31/36, A61K31/37
Quick answer
US 8071545 (Therapies and compositions for controlling the stress mechanism and for stabilizing hemostasis in an organism) is held by Lewis S. Coleman, MD, Inc.. Status: granted. Granted Dec 6, 2011. Expires Dec 1, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Lewis S. Coleman, MD, Inc.
- Grant date
- Expiration
- Claims
- 22
- CPC classes
- A61K, A61K31/36, A61K31/37
More from Lewis S. Coleman, MD, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12428379
Acylsulfonamide KAT6A inhibitors
granted -
US 12370181
Regimens of estrogen receptor antagonists
granted -
US 11672785
Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs
granted -
US 11229630
Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs
granted -
US 10624878
Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs
granted -
US 10292971
Tetrahydro-1H-pyrido[3,4-b]indole anti-estrogenic drugs
granted -
US 9018244
Benzopyran compounds, compositions and uses thereof
granted
Frequently asked questions
What is US patent 8071545?
US 8071545 (Therapies and compositions for controlling the stress mechanism and for stabilizing hemostasis in an organism) is held by Lewis S. Coleman, MD, Inc.. Status: granted. Granted Dec 6, 2011. Expires Dec 1, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8071545?
Lewis S. Coleman, MD, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 8 pharmaceutical patents for this assignee.
When does US 8071545 expire?
Our index shows an expiration date of Dec 1, 2031 (5 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.